These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24504769)

  • 1. Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease.
    Fisk M; Gajendragadkar PR; Mäki-Petäjä KM; Wilkinson IB; Cheriyan J
    Am J Cardiovasc Drugs; 2014 Jun; 14(3):155-65. PubMed ID: 24504769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
    Docena G; Rovedatti L; Kruidenier L; Fanning A; Leakey NA; Knowles CH; Lee K; Shanahan F; Nally K; McLean PG; Di Sabatino A; MacDonald TT
    Clin Exp Immunol; 2010 Oct; 162(1):108-15. PubMed ID: 20731675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.
    Chopra P; Kanoje V; Semwal A; Ray A
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1411-25. PubMed ID: 18808304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua.
    Shoji T; Yoshida S; Mitsunari M; Miyake N; Tsukihara S; Iwabe T; Harada T; Terakawa N
    J Reprod Immunol; 2007 Oct; 75(2):82-90. PubMed ID: 17617469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 MAP kinase inhibitors: many are made, but few are chosen.
    Dominguez C; Powers DA; Tamayo N
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):421-30. PubMed ID: 16022178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages.
    Bhattacharyya A; Pathak S; Datta S; Chattopadhyay S; Basu J; Kundu M
    Biochem J; 2002 Nov; 368(Pt 1):121-9. PubMed ID: 12150710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.
    Kaminska B
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):253-62. PubMed ID: 16198162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 pathway kinases as anti-inflammatory drug targets.
    Schindler JF; Monahan JB; Smith WG
    J Dent Res; 2007 Sep; 86(9):800-11. PubMed ID: 17720847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease.
    Feng YJ; Li YY
    J Dig Dis; 2011 Oct; 12(5):327-32. PubMed ID: 21955425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases.
    Yasuda S; Sugiura H; Tanaka H; Takigami S; Yamagata K
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):45-59. PubMed ID: 20812905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives.
    Pelaia C; Vatrella A; Sciacqua A; Terracciano R; Pelaia G
    Expert Rev Respir Med; 2020 May; 14(5):485-491. PubMed ID: 32077346
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitors of p38 mitogen-activated protein kinase: potential as anti-inflammatory agents in asthma?
    Newton R; Holden N
    BioDrugs; 2003; 17(2):113-29. PubMed ID: 12641490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, rac1, and reactive oxygen species.
    Pomerance M; Abdullah HB; Kamerji S; Correze C; Blondeau JP
    J Biol Chem; 2000 Dec; 275(51):40539-46. PubMed ID: 11006268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor.
    Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC
    Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies.
    Pelaia C; Vatrella A; Gallelli L; Lombardo N; Sciacqua A; Savino R; Pelaia G
    Drug Des Devel Ther; 2021; 15():1275-1284. PubMed ID: 33790539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology.
    Ng DC; Long CS; Bogoyevitch MA
    J Biol Chem; 2001 Aug; 276(31):29490-8. PubMed ID: 11382751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
    Page TH; Brown A; Timms EM; Foxwell BM; Ray KP
    Arthritis Rheum; 2010 Nov; 62(11):3221-31. PubMed ID: 20589681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensation of Adiponectin-Induced Adenosine Monophosphate-Activated Protein Kinase and p38 Mitogen-Activated Protein Kinase Signaling in Rheumatoid Arthritis Synovial Fibroblasts.
    Khawaja K; Frommer KW; Bausch M; Rehart S; Müller-Ladner U; Neumann E
    J Interferon Cytokine Res; 2021 May; 41(5):177-186. PubMed ID: 34003681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor.
    Terajima M; Inoue T; Magari K; Yamazaki H; Higashi Y; Mizuhara H
    Eur J Pharmacol; 2013 Jan; 698(1-3):455-62. PubMed ID: 23183108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.